---
title: "Oncolytics Biotech Inc. (ONCY.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ONCY.US.md"
symbol: "ONCY.US"
name: "Oncolytics Biotech Inc."
industry: "Biotechnology"
datetime: "2026-05-20T12:01:16.274Z"
locales:
  - [en](https://longbridge.com/en/quote/ONCY.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ONCY.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ONCY.US.md)
---

# Oncolytics Biotech Inc. (ONCY.US)

## Company Overview

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of gastrointestinal (“GI”) tumors, metastatic colorectal cancer, anal cancer, and metastatic pancreatic cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |
| Website | [oncolyticsbiotech.com](https://oncolyticsbiotech.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.70 | 287 | - | - | - |
| PB | -17.54 | 533 | 1284.91 | 29.13 | 21.72 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-19T04:00:00.000Z

Total Analysts: **6**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 17% |
| Overweight | 3 | 50% |
| Hold | 1 | 17% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.78 |
| Highest Target | 10.12 |
| Lowest Target | 2.96 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ONCY.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ONCY.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ONCY.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ONCY.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**